Skip to content
20-F

Annual Report (Foreign)

Baird Medical Investment Holdings Ltd BDMD BDMDW

0001410578-25-001328

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 35.73M sh
Long Term Debt FY 2024 · Dec 31, 2023 $1.61M
Short Term Debt FY 2024 · Dec 31, 2023 $817.49K
Stockholders Equity FY 2024 · Dec 31, 2023 $35.75M
Current Liabilities FY 2024 · Dec 31, 2023 $18.98M
Total Liabilities FY 2024 · Dec 31, 2023 $21M
Current Assets FY 2024 · Dec 31, 2023 $40.08M
Total Assets FY 2024 · Dec 31, 2023 $56.71M
Shares Diluted FY 2024 · Dec 31, 2022 25.56M sh
Capex FY 2024 · Dec 31, 2022 $5.91M
Operating Cash Flow FY 2024 · Dec 31, 2022 $485.97K
Eps Diluted FY 2024 · Dec 31, 2022 $0.49
Eps Basic FY 2024 · Dec 31, 2022 $0.49
Sga Expense FY 2024 · Dec 31, 2022 $6.96M
Rd Expense FY 2024 · Dec 31, 2022 $3.86M
Operating Income FY 2024 · Dec 31, 2022 $13.63M
Gross Profit FY 2024 · Dec 31, 2022 $28.04M
Cost Of Revenue FY 2024 · Dec 31, 2022 $7.05M
Revenue FY 2024 · Dec 31, 2022 $35.09M